Intelligence · Clinical Development
Pipeline search results
Programs matching “asthma” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 226 pipeline programs matching "asthma" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Rademikibart in prefilled syringe
S.L
Asthma Acute
1 trial -
Reslizumab
Teva Pharma GmbH
Severe Asthma
1 trial -
Rocatinlimab
Amgen
Asthma
1 trial -
SAR440340
Regeneron UK Limited
Asthma
1 trial -
SERETIDE Rotacaps
GlaxoSmithKline
Asthma
1 trial -
TD-8236
Theravance Biopharma Ireland Umited
Asthma
2 trials -
TEV-48574
Teva Pharma GmbH
Asthma
1 trial -
TEV-53275 Dose A
Teva Pharma GmbH
Asthma
1 trial -
Tozorakimab
AstraZeneca
Asthma
1 trial -
Tralokinumab 300 mg, Q2W
MedImmune
Asthma
1 trial -
albuterol inhalation powder
Amphastar France Pharmaceuticals
Asthma
1 trial -
pioglitazone
Takeda
Asthma
1 trial -
tiotropium-bromide
Boehringer Ingelheim
Asthma
1 trial -
20230151
Amgen
Asthma
1 trial -
219729
GlaxoSmithKline
Mild Asthma
1 trial -
610
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
add-on Maintenance Treatment of Patients With Severe Eosinophilic Asthma
1 trial -
610 30mg group
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Asthma
1 trial -
95597528EDI1001
Janssen-Cilag International N.V.
Mild to Moderate Asthma
1 trial -
A160_01AD2502
Lacuna Pharma Pty Ltd
Phase I study in healthy participants. Intended indication: atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, prurigo nodularis, and chronic obstructive pulmonary disease
1 trial -
APG777
Apogee Therapeutics
Asthma
1 trial -
ARO-RAGE Injection
Arrowhead Pharmaceuticals Ireland Limited
Asthma
1 trial -
ATI-052-ASTH-101
Aclaris Therapeutics
Mild to Moderate Asthma
1 trial -
AZD0449
AstraZeneca
Asthma
1 trial -
Albuterol dry powder inhaler
Teva Pharma GmbH
Asthma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.